‘It just looks different': Government looking to phase out artificial dyes from U.S. food supply
The goal is to replace the dyes with natural alternatives.
One grocer in the Ozarks already carries foods that are free from artificial colors.
'The new laws coming down, Mama Jeans already has got that covered here,' said Lucinda Soden, the logistics manager for Mama Jeans Natural Market
Soden says the idea for Mama Jeans came about when the founder realized there was a need for a grocery store where people with food allergies could go and not worry about the labels.
'We're an all-natural market, which means that we have all-natural and organic products,' Soden said.
The announcement came Tuesday, April 22, from the Department of Health and Human Services and the Food and Drug Administration (FDA).
'Increasingly the public is seeing the value in addressing the toxic soup that their kids are being raised in,' said FDA Commissioner Marty Makary.
The government is working to phase out all petroleum-based synthetic dyes.
'If they wanna add petroleum, they wanna eat petroleum they ought to add it themselves at home,' Kennedy said. 'They shouldn't be feeding it to the rest of us.'
Soden tells Ozarks First this food dye ban will mainly affect kids' foods.
'A lot of the cereals just kind of look, you know, they don't look as exciting, but some of the candies do,' Soden said.
Some of the foods impacted include cereals like Fruit Loops and Trix, and candy like M&Ms and Skittles.
Soden says despite the lack of dyes, their food doesn't taste any different.
'No, absolutely not,' Soden said. 'It just looks different.'
The food dye industry has denied any safety concerns with artificial dyes. The International Association of Color Manufacturers said the dyes help with consistency and consumer trust in food products.
'We have a food addiction problem,' Makary said. 'In fact obesity is a food addiction manifestation. And so the problem is not better willpower. The problem is examining the ingredients for making food so addictive.'
The eight artificial dyes expected to be phased out of U.S. food supply by the end of 2026 are Citrus Red No. 2 and Orange B, FD&C Green No. 3, FD&C Red No. 40, FD&C Yellow No. 5, FD&C Yellow No. 6, FD&C Blue No. 1, and FD&C Blue No. 2.
When asked about the price difference between foods with and without artificial dyes, Soden says it is a sacrifice to buy foods without those dyes but she says she believes it's worth it.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
37 minutes ago
- Yahoo
High Noon Just Recalled Thousands Of 12-Packs Mislabeled As Celsius Energy Drinks
After seeing the effects of caffeine and alcohol in a Four Loko, the US Food and Drug Administration banned production of drinks containing both. However, while caffeine and alcohol are both involved, High Noon's recall of thousands of its products and Celsius Energy Drink 12-packs is a little different thanks to a labeling error. On July 29, 2025, High Noon issued a voluntary recall of two production lots of its Beach Variety 12-ounce 12-packs. But what makes this recall unique is that a packaging supplier mistake also roped in Celsius Energy Drink, owned by Celsius Holdings. It's common for drink producers to share suppliers who actually manufacture and distribute cans to factories. Per High Noon's announcement, the supplier accidentally sent empty cans for Celsius's Astro Vibe Sparkling Blue Razz drink to High Noon, which were then filled with vodka seltzer. Factory workers then mistakenly added these mislabeled cans to Beach Variety 12-packs, risking accidental alcohol consumption for consumers who may not have noticed. While hard seltzers occupy a murky area of alcohol classification between the FDA, Alcohol and Tobacco Trade and Tax Bureau, and the Federal Alcohol Administration Act, mislabeling of any product is a serious issue, especially when alcohol is involved. While this recall is not quite as serious for the general public as a Class One recall of foodstuffs, recent purchasers of High Noon Beach Variety 12-packs should take steps to ensure their products do not fall under the recall. Read more: 6 Inexpensive Tequilas To Buy And 6 To Avoid, According To Bartender How To Identify Recalled High Noon And Celsius Energy Drinks While most alcohol vendors and grocery stores throw out recalled food, it still may be on the consumer to determine if they have a mislabeled product. Though the recall only affects Florida, Michigan, New York, Ohio, Oklahoma, South Carolina, Virginia, and Wisconsin, anyone who purchased a High Noon Beach Variety Pack recently or may consume a Celsius Astro Vibe Sparkling Blue Razz energy drink should carefully evaluate the packaging. This is especially true for anyone under the legal drinking age, may be pregnant, or who abstains from alcohol. Universal Product Codes (UPC) are retail codes used to track sales of a specific inventory item, but they also help in situations like this. In its announcement, High Noon said the UPC for affected High Noon packages is 085000040065 and the UPC for affected Celsius packages is 8 89392 00134 1. Lot Codes denote specific batches that use the same materials and are great for helping companies determine which products may be affected by recalls. See High Noon's announcement on the FDA website for the lot codes. If you can't determine if your product is affected by the codes, the unique situation of this recall created an obvious physical indicator. While normal Sparkling Blue Razz flavored drinks have a black lid, affected batches have the silver lid found on High Noon cans. To avoid drinking a mislabeled beverage, avoid any can of this flavor that does not have the correct color of lid. Want more food knowledge? Sign up to our free newsletter where we're helping thousands of foodies, like you, become culinary masters, one email at a time. Read the original article on Food Republic. Solve the daily Crossword
New York Post
an hour ago
- New York Post
AI-powered exoskeletons are helping paralyzed patients walk again — and could soon be coming to homes across the U.S.
Inside the glass-ensconced Wandercraft storefront on Park Avenue South, Caroline Laubach recently rose from her wheelchair and walked. 'Every time I get up I remember how tall I really am,' Laubach, a 22-year-old from Pennsylvania, told NYNext. At age 18, Laubach went into end-stage heart failure. For two weeks, she lingered on life support while doctors scrambled to find a donor. She ultimately had a successful heart transplant, but not before a spinal stroke left her paralyzed from the waist down. 10 Three years after a spinal stroke left her paralyzed, Caroline Laubach now walks weekly with the help of an exoskeleton from Wandercraft called Eve. Emmy Park She thought she would be confined to a wheelchair for the rest of her life, then she met Wandercraft's Atalante. During a therapy session in November 2024, she strapped on the exoskeleton for the first time. It was life-changing. 'To look at somebody from eye-level and have a connection with them in that way,' she said. 'It's a different dynamic.' 10 In December 2023, Wandercraft debuted its flagship U.S. space — a street-level showroom and clinic called Walk In New York. Emmy Park Founded in 2012, the French robotics and AI company Wandercraft launched its first model of Atalante in 2019. The device received FDA clearance for stroke rehabilitation two years later. In December 2023, Wandercraft opened a headquarters and showroom in New York. It's betting that its exoskeletons can help redefine mobility for people with spinal cord injuries, strokes and other conditions affecting gait and balance. 'We are not just a technology [confined to] cool video demonstrations in the lab,' Matthieu Masselin, CEO and co-founder of Wandercraft, told NYNext. 'We are working with real people, real patients.' 10 'I was born completely healthy — as far as we knew,' Caroline Laubach (left) told NYNext's Lydia Moynihan (right). At 18, Laubach went into end-stage heart failure and spent two weeks on life support awaiting a transplant. During that time, she suffered a spinal stroke that left her paralyzed from the waist down. Emmy Park 10 Laubach can control Eve with a handheld joystick, using buttons to walk forward, turn, squat and even bend side to side — all without assistance. Emmy Park Unlike other exoskeletons that require crutches, both Atalante and Wandercraft's newer model, Eve, are fully self-balancing. The former is designed specifically for physical therapy and requires the assistance of a clinician. The latter, now in clinical trials at the Bronx VA and Kessler Rehabilitation Center in New Jersey, can be fully controlled by the user and is built for personal use in home and real-world environments. Wandercraft's exoskeletons are powered by multiple motors — two at the ankles, one at each knee and several at the hips — plus a suite of sensors that constantly track weight distribution. As the user shifts or moves, the system processes inputs in real time to maintain balance and posture. 10 While Atalante (right) is used in rehab centers under therapist supervision, Eve (left) is untethered, joystick-controlled and intended for everyday use outside the clinic. Emmy Park 10 Masselin, who co-founded Wandercraft in 2012, left Paris and moved to New York about three years ago to help bring the company's vision to life in the U.S. Emmy Park From weight and height to balance and stride, every patient moves differently. To ensure safety, Wandercraft has spent more than a decade refining its control algorithms and AI systems with collaborators like Nvidia and AWS. It's tested its hardware with more than 2,000 patients in hospitals and rehab centers. 10 French paraplegic tennis player Kevin Piette wore a Wandercraft exoskeleton while carrying the Olympic torch through Paris ahead of the 2024 Games. Courtesy of Wandercraft One prominent patient is French paraplegic tennis player Kevin Piette, who donned a Wandercraft exoskeleton to carry the Olympic torch towards Paris ahead of the 2024 Games. 'Emotionally, psychologically, physiologically … [we're seeing] the benefits on so many aspects of [the patients'] lives,' Masselin said. 10 Thanks to improved engineering and streamlined production, Wandercraft's exoskeletons are steadily becoming cheaper to produce — and a new partnership with the Renault Group, Masselin said, will drive costs down even further. Emmy Park Wandercraft devices are currently used in more than 100 institutions across Europe and America, and access is expanding. The company recently received Medicare coding for Atalante, meaning qualifying patients will be reimbursed. When Eve hits the market,potentially as soon as next year, it will be eligible for reimbursement up to $93,000. 10 As part of its partnership with the Renault Group, Wandercraft has co-developed CALVIN-40 — a humanoid robot that can support manufacturing workflows. Courtesy of Wandercraft 10 Masselin said that future iterations of the exoskeletons will be equipped for less even terrain and consistent surfaces like stairs and sand. Emmy Park To help scale, Wandercraft partnered with the Renault Group in June to streamline manufacturing and reduce costs. As part of the partnership, Wandercraft is also developing a new line of humanoid robots that can slot into the manufacturing process. To Masselin, who relocated from Paris three years ago to lead US expansion, the future of the technology lies in its adaptation to broader environments — stairs, outdoor terrain, even beaches — and in building devices that respond to how people actually live. This story is part of NYNext, an indispensable insider insight into the innovations, moonshots and political chess moves that matter most to NYC's power players (and those who aspire to be). Laubach, for her part, hopes to be among the first to take Eve home once FDA clearance is granted. 'I hope we see a lot more exoskeletons out on the street,' she told NYNext, 'for people like me — and people very different from me.' Send NYNext a tip: nynextlydia@
Business Wire
an hour ago
- Business Wire
EvoEndo® Endoscopy System Receives FDA Clearance for All Ages
DENVER--(BUSINESS WIRE)-- EvoEndo ®, Inc. (EvoEndo) announces that the EvoEndo® Model LE Gastroscope is now FDA-cleared for patients of all ages — from neonates to adults. Since 2022, the EvoEndo System has been the only option available for sedation-free transnasal endoscopy for pediatric patients five and older. Now, the expanded indication makes safe, transoral endoscopy available to infants and young children, a previously underserved population. In just three years, EvoEndo has redefined what's possible – and who it's possible for. 'This expanded clearance is a major step forward,' stated pediatric gastroenterologist Dr. Michael Manfredi. CEO Jonathan Hartmann remarked, 'EvoEndo was the first to achieve FDA clearance for an ultra-slim endoscope for pediatric patients, age five and older. We continue to innovate and are pleased to announce that we have expanded our indication to include all patients. The EvoEndo endoscopy system is now FDA-cleared for use with no age restrictions, elevating care for newborns and infants who will benefit from our ultra-slim technology.' The new indication firmly establishes EvoEndo as the leading choice for all endoscopies, from sedated transoral procedures in babies to sedation-free transnasal procedures preferred by older pediatric and adult patients. 'This expanded clearance is a major step forward,' stated pediatric gastroenterologist Dr. Michael Manfredi. He added, 'Being able to use the EvoEndo system in children under five allows us to safely support diagnosis and care in even the youngest patients. It also opens the door to broader applications beyond transnasal endoscopy, giving pediatric specialists more flexibility to deliver safer, more effective care for this vulnerable population.' According to co-founder and CMO Dr. Joel Friedlander, the new indication 'enables gastroenterologists and pediatric surgeons to provide care for patients across the entire age spectrum.' ChannelMax® technology accommodates most standard pediatric accessories, and with scopes available in both 85 and 110 cm lengths, they are suitable for small or challenging anatomy and a broad range of indications. The EvoEndo System is lightweight, portable, and easily scalable to multiple settings, allowing for care at the site of service. This makes diagnostic and therapeutic endoscopy more accessible, timely, and convenient for both patients and physicians. EvoEndo remains committed to expanding access and elevating the standard of care for every patient and is already available in over 40 facilities nationwide, with additional locations coming soon. Indications for Use The EvoEndo Model LE Gastroscope is intended for the visualization of the upper digestive tract in adults and pediatric patients, specifically for the observation, diagnosis, and endoscopic treatment of the esophagus, stomach, and duodenal bulb. The gastroscope is a sterile, single-use device and can be inserted orally or transnasally. The EvoEndo Controller is intended for use with an EvoEndo Endoscope for endoscopic diagnosis, treatment, and video observation. To learn more, please visit
